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Abstract
Background: There is a major paradox in our understanding of honey bee immunity: the high
population density in a bee colony implies a high rate of disease transmission among individuals, yet
bees are predicted to express only two-thirds as many immunity genes as solitary insects, e.g.,
mosquito or fruit fly. This suggests that the immune response in bees is subdued in favor of social
immunity, yet some specific immune factors are up-regulated in response to infection. To explore
the response to infection more broadly, we employ mass spectrometry-based proteomics in a
quantitative analysis of honey bee larvae infected with the bacterium Paenibacillus larvae. Newly-
eclosed bee larvae, in the second stage of their life cycle, are susceptible to this infection, but
become progressively more resistant with age. We used this host-pathogen system to probe not
only the role of the immune system in responding to a highly evolved infection, but also what other
mechanisms might be employed in response to infection.
Results: Using quantitative proteomics, we compared the hemolymph (insect blood) of five-day
old healthy and infected honey bee larvae and found a strong up-regulation of some metabolic
enzymes and chaperones, while royal jelly (food) and energy storage proteins were down-
regulated. We also observed increased levels of the immune factors prophenoloxidase (proPO),
lysozyme and the antimicrobial peptide hymenoptaecin. Furthermore, mass spectrometry evidence
suggests that healthy larvae have significant levels of catalytically inactive proPO in the hemolymph
that is proteolytically activated upon infection. Phenoloxidase (PO) enzyme activity was
undetectable in one or two-day-old larvae and increased dramatically thereafter, paralleling very
closely the age-related ability of larvae to resist infection.
Conclusion: We propose a model for the host response to infection where energy stores and
metabolic enzymes are regulated in concert with direct defensive measures, such as the massive
enhancement of PO activity.
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Background
Honey bees, Apis mellifera, face a number of niche-specific
pathogens such as the endospore-forming bacterium
Paenibacillus larvae, the causative agent of American Foul-
brood (AFB) [1]. Bees are only susceptible to P. larvae dur-
ing the first 48 h following eclosion (egg hatching), in
their first and second instar developmental stages. It
remains unclear why larvae acquire immunity against P.
larvae  after the third instar, whereas the ingestion of
merely 10 spores can cause systemic infection and death
in the previous instars [2]. It was thought that P. larvae
spores germinate in the larval midgut and enter the epi-
thelium by phagocytosis [3,4] but recent data suggest that
the bacteria follow a paracellular route to breach the epi-
thelial wall [5]. The effectiveness of the antimicrobial pep-
tide (AMP) defensin against P. larvae was documented in
growth inhibition assays [6,7] using fractionated royal
jelly (honey bee food). However, Evans et al. found no
changes in defensin gene expression in larvae fed P. larvae
spores and, paradoxically, that abaecin (another AMP)
gene expression was greatest in newly eclosed larvae [8,9],
the most susceptible stage. More recently, the same group
showed that infection caused elevated expression of Toll-
like receptor, MyD88 and IκB [10]. Thus, even though
they do not always respond as expected, honey bees have
all the components of an innate immune system. Here we
explore the response of this system to a physiologically
relevant infection in a natural setting.
To this end, hemolymph (arthropod blood) is well-suited
for studying insect immunity; it is especially relevant in
the case of P. larvae as the bacterium contacts hemolymph
as soon as it breaches the gut epithelium. This fluid con-
tains antimicrobial factors produced largely by the fat
body and, to a lesser extent, hemocytes. These cells can
also respond to infectious particles by phagocytosing
them or by autolysis, which is part of an encapsulation
pathway used to inhibit growth of microorganisms. Like-
wise, as the connective tissue responsible for transporting
various molecules throughout the body, it is also opti-
mally suited for monitoring systemic changes in other
pathways. Previously, we have examined how hemol-
ymph changes during normal larval development [11]. In
that study we observed that most immune factors were
not significantly altered during development, with only
the AMP apismin and the monooxygenase prophenoloxi-
dase showing any age-related changes in expression. Thus,
based on our earlier work and that of others [8-12], we
expected that a P. larvae infection should induce, in hemo-
lymph, elevated levels of at least some AMPs, as well as
other antibacterial enzymes such as lysozyme and proph-
enoloxidase. To address these predictions, we use mass
spectrometry (MS)-based proteomics to measure changes
in hemolymph protein levels in larvae challenged with P.
larvae. Furthermore, we predict that a protein that is able
to convey immunity to older larvae and adults must be
expressed at extremely low levels in the susceptible early
larval instars. Using a functional assay, we demonstrate
how one potentially critical player in host defense, phe-
noloxidase (PO), correlates with larval resistance to infec-
tion.
Results
Different strains of P. larvae produce equivalent outcomes
In order to test the response of worker larvae to P. larvae
infection, we spray-inoculated a small section of comb
containing one-day-old worker larvae with either (A) a
homogenate of scale from natural infections of P. larvae
(PL-Scale) or (B) a laboratory-cultured strain of P. larvae
(NRRL B-3650, PL-Lab). We used two sources of P. larvae
as we had no a priori knowledge regarding their relative
pathogenicity. Four days post-infection we harvested
hemolymph from 5-day larvae and compared the protein
expression in the two infected conditions versus an unin-
fected control using a quantitative proteomics approach
[11]. Using an ultra-high accuracy/resolution LTQ-Orbit-
rapXL, we identified a combined total 331 proteins (listed
in Additional Files 1 and 2) with an estimated false dis-
covery rate of 0.30%. Protein regulation differed between
bees infected with the PL-Lab strain compared to the PL-
Scale strain (Fig 1a, p < 0.0001) but among the 25 pro-
teins quantified in both infections (Fig 1b) that were sig-
nificantly different from control (p < 0.05), 40% (10)
were higher in PL-Scale and 60% (15) were higher in PL-
Lab. Thus, while there were differences between the inoc-
ulums, they were not consistently in one direction and so
there was not enough evidence to reject the null hypothe-
sis that regulation among these shared proteins differed
between the two strains (Wilcoxon matched-pairs signed-
ranked test, p = 0.87).
Diseased honey bee larvae express higher levels of 
mitochondrial metabolic enzymes
A total of 33 proteins, out of 179 quantified, were regu-
lated by a magnitude of at least 2-fold for either one or
both inoculums (p < 0.05 or p < 0.01, two-tailed, non-par-
ametric Wilcoxon matched-pairs signed-ranked statistical
test, full results listed in Additional File 3). Among the
most up-regulated of all quantified proteins were several
mitochondrial metabolic enzymes (Fig 2a). One malate
dehydrogenase (MDH) [GI:66513092], for example,
showed about a 14-fold increase by both infection meth-
ods (p < 0.01). This bee MDH is 67% identical to human
mitochondrial MDH2 [GI:12804929], implying its direct
participation in the mitochondrial matrix and the tricar-
boxylic acid (TCA) cycle, instead of the malate-aspartate
shuttle that is carried out by human MDH1
[GI:66506786]. Further to this point, the levels of aspar-
tate aminotransferase, another major enzyme of this shut-
tle, showed no change. An aldehyde dehydrogenaseBMC Genomics 2009, 10:387 http://www.biomedcentral.com/1471-2164/10/387
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(ALDH) [GI:66530423], a homolog of the human mito-
chondrial isoform [GI:118504] was up-regulated 25-fold
(p < 0.01) in PL-Lab-infected samples, and the same trend
was observed in infection with PL-Scale, although it did
not reach statistical significance (p < 0.1). Acetyl-CoA
acyltransferase [GI:48097100], which participates in beta-
oxidation and the mevalonate pathway, was significantly
(p < 0.01) up-regulated at 14- and 9-fold in PL-Scale and
PL-Lab, respectively.
Infected larvae deplete their energy stores during infection
Clearly the metabolic capacity of larvae is undergoing a
massive change in response to infection (Fig 2a), suggest-
ing that concerted changes may also be occurring in their
energy stores. Food proteins, which comprise a family
called the major royal jelly proteins (MRJPs), are consist-
ently depleted (Fig 2b), except in one case that was not sig-
nificant at the p < 0.05 level. At the same time, 5 d larvae
should be accumulating enormous levels of hexamerin
(HEX) proteins in the hemolymph [11] as an amino acid
source for later growth in the pupal stage. However,
HEX110 [GI:110761029], HEX70b [GI:58585148] and
HEX70c [GI:66549815] have a modest but significant (p
< 0.01) 2- to 3-fold decrease under PL-Lab infection con-
ditions (Fig 2c). Similar reductions were seen for two lipid
carriers, retinoid- and fatty-acid binding protein
[GI:110758758] and apolipophorin III [GI:66557660],
while a putative neuropeptide Y (NPY) receptor
[GI:110764421] that may regulate food intake was
strongly up-regulated by the PL-Lab infection (p < 0.05)
The protein-folding/quality control machinery is over-
expressed in response to infection
Protein-folding chaperones and heat-shock proteins
(HSPs) have been implicated in disease responses due to
stress associated with tissue damage [13], with evidence
that they also have roles in signal transduction in immune
pathways [14]. Twenty-six molecular chaperones were
detected in larval hemolymph, with many being up-regu-
lated 3- to 20-fold in diseased larvae (Fig 2d). Among
them are three proteins with multiple domains homolo-
gous to disulfide isomerases ([GI:110768510],
[GI:66546657], [GI:66531851]), a 90 kDa heat shock
protein HSP90 [GI:110758921], a 60 kDa heat shock pro-
tein HSP60 [GI:66547450] and a heat shock cognate 5
homolog [GI:66501507]. In human studies, heat shock
proteins such as HSP60 have been repeatedly linked to
macrophage activation [15,16]. Hemocytes, being some-
what similar to macrophages in their phagocytic capacity,
have been noted to undergo morphological changes dur-
ing AFB infection, while at the same time populations of
other hemolymphic cells increase [17] so these effects
may be linked with the HSP up-regulation observed here.
Lysozyme and hymenoptaecin levels increase with 
bacterial challenge
We were able to identify four low molecular weight
defense proteins: lysozyme [GI:66565246], hymenoptae-
cin [GI:58585174], apidaecin 22 [GI:58585226], and
defensin [GI:58585176]. We observed a 13-fold increase
of lysozyme in PL-Lab infections (p < 0.01) and a 16-fold
Peptide ratios from two different infection methods Figure 1
Peptide ratios from two different infection methods. 
Hemolymph was collected from infected and healthy 5-day 
old larvae. In (a), ratios of the 1207 peptides concomitantly 
quantified two different infection methods is shown. In (b), 
twenty-five proteins quantified with a minimum of 95% confi-
dence are shown. All values are shown in natural log scale, 
relative to the control hemolymph (PL-Scale, x-axis, PL-Lab, 
y-axis). Linear regression is represented by the diagonal lines: 
(a) slope = 0.69, y-intercept = 0.28, R2 = 0.29; (b) slope = 
0.85, y-intercept = 0.041, R2 = 0.76.
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American Foulbrood-induced changes in protein expression regulation in selected functional families Figure 2
American Foulbrood-induced changes in protein expression regulation in selected functional families. Pro-
teomes of honey bee hemolymph from larvae (5 days after hatching) infected using methods PL-Scale (Sc) or PL-Lab (Lb) were 
compared with healthy controls. Relative levels are expressed in the natural log scale (y-axis), with the level from uninfected 
bees defined at 0. Data points are relative peptide ratios pooled from 3 biological replicates, with the horizontal bar represent-
ing the median level of protein regulation. Those with the median beyond 2-fold (outside of the shaded box) and meets statis-
tical significance, as calculated by the two-tailed Wilcoxon matched-pairs signed-ranked test are marked by a single (*, p < 0.05) 
or double (**, p < 0.01) asterisk. Selected proteins and functional families are shown: (a) highly regulated metabolic proteins, 
(b) major royal jelly proteins, (c) energy storage proteins, (d) protein folding chaperones, and (e) immunity-related proteins. 
NA = unquantifiable proteins. Protein abbreviations in alphabetical order (name, accession number): ACAT (acetyl-CoA acyl-
transferase, [GI:48097100]); ALDH (aldehyde dehydrogenase, [GI:66530423]); apoLIII (apolipophorin III, was "hypothetical 
protein", [GI:66557660]); Eater (a homolog identified by [10], [GI:110763407]); ECHD (enoyl-Coa hydratase, [GI:110773271]); 
ERp60 (a homlog of protein disulfide isomerase, [GI:66546657]); FABP (retinoid- and fatty acid binding protein, 
[GI:110758758]); Gly93 (glycoprotein 93, a homolog of HSP90, [GI:110758921]); GNBP1 (Gram-negative binding protein 1, 
[GI:110755978]); H70/90 (HSP70/90 organizing protein, [GI:110756123]); HEX110 (hexamerin 110, was "larval serum protein 
2", [GI:110761029]); HEX70b (hexamerin 70b, [GI:58585148]); HEX70c (hexamerin 70c, was "hexamerin 2 beta", 
[GI:66549815]); HSC5 (heat shock protein cognate 5, [GI:66501507]); HSC70Cb (heat shock cognate 70Cb, [GI:66505007]); 
HSP1 (heat shock protein 1, [GI:110749824]); HSP60 (heat shock protein 60, [GI:66547450]); HSP8 (heat shock protein 8, 
[GI:66537940]); HSP90 (heat shock protein 90, [GI:66512625]); Hympt (hymenoptaecin, [GI:58585174]); Lys (lysozyme, 
[GI:66565246]); MDH (malate dehydrogenase, 66513092); MRJP1 (major royal jelly protein 1, [GI:58585098]); MRJP2 (major 
royal jelly protein 2, [GI:58585108]); MRJP3 (major royal jelly protein 3, [GI:58585142]); PDI (disulfide isomerase, 
[GI:110768510]); PDI (disulfide isomerase, [GI:66531851]); pPO (prophenoloxidase, [GI:58585196]); pPO-a (prophenoloxi-
dase-activating factor, [GI:110758534]); Serpin (serine protease inhibitor 5, [GI:66566441]); TCP1 (a homlog of chaperonin, 
[GI:66560172]).
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increase of hymenoptaecin (Fig 2e) but there were too few
peptides detected for apidaecin 22 and defensin to meet
our criteria for quantitation (see Materials and Methods).
Other immune factors that were identified but did not
appear to be regulated by infection include a Gram-nega-
tive bacteria binding protein [GI:110755978], peptidogly-
can recognition protein (PGRP) SA [GI:110765019] and
PGRP SC2 [GI:66522804], suggesting that the response
seen for lysozyme and hymenoptaecin is a specific
response to P. larvae infection.
ProPO expression and proteolytic activation are enhanced 
during infection
The melanization cascade, which leads to the encapsula-
tion of infectious agents, is one of the most important
defensive mechanisms of insect innate immunity. One of
the central steps in this mechanism is the cleavage of
proPO to PO, the active form of the monooxygenase. The
PO enzyme, which is activated by proteolytic action, catal-
yses a key step in the synthesis of melanin and plays a cru-
cial role in melanotic encapsulation of invaders [18]. We
observed a 4-fold increase (p < 0.01) in the expression of
proPO in PL-Scale-infected larvae and a 5-fold increase (p
< 0.01) in PL-Lab-infected larvae (Fig 2e). The tryptic pep-
tide SVATQVFNR, whose C-terminus is the predicted
propeptide cleavage site [19], was elevated by about 10-
fold compared to tryptic peptides found in the remainder
of the protein (Fig 3). The higher ratios for this propeptide
versus the other peptides of the protein suggest that the
increased PO response during infection is largely due to
the proteolytic activation of an existing pool of PO in the
hemolymph and only partially attributable to up-regu-
lated expression.
Phenoloxidase activity is not found in the first two days of 
larval development, but increases sharply afterwards
Although PO is well-known for its activity against patho-
gens, there is little indication so far that its expression
level affects the outcome of infection by P. larvae. Recent
data from our group suggests that proPO levels correlate
positively with age [11], but we had been unable to estab-
lish a full profile of proPO levels during the entire course
of larval development due to the low absolute levels of
expression. A PO activity assay [20], used to test for the
oxygenation of monophenols to diphenols and diphenols
to quinones [21], should be more sensitive than mass
spectrometry and so was employed here to detect PO
activity in developing, healthy larvae. PO activity was eas-
ily detected in crude hemolymph from fourth- to fifth-
instar honey bee larvae but there are at least two gene
products in the honey bee genome that could function in
this assay based on domain comparisons [22]. To deter-
mine which of the two possible proteins is responsible for
the PO activity in hemolymph, hemolymph from healthy,
fourth and fifth instar larvae was fractionated by strong
anion exchange chromatography and the PO activity in
each fraction was correlated (Fig 4a) with the abundance
of each protein [23]. The measurement of relative proPO
levels was accomplished using differential isotopic labe-
ling of peptides in each fraction, selecting one fraction as
the reference to compare against the others (Fig 4b). The
PO activity profile matched very closely to the levels of the
gene product annotated as 'prophenoloxidase'
[GI:58585196] across the chromatographic fractions and
matched very poorly to HEX70b, which also has a putative
phenoloxidase catalytic domain.
Conceivably, older larvae can boost PO activity in
response to infection, but could a lack of PO activity in the
early larval stages explain the susceptibility of young lar-
vae to P. larvae infection? Cell-free hemolymph was
extracted from healthy larvae one to five days after
eclosion and tested for PO activity and, indeed, there was
no detectable activity in the first two days of development,
with some activity detected in day three and substantial
activity thereafter (Fig 5).
Discussion
Here we have used a quantitative proteomics approach to
compare the proteomes of healthy and P. larvae-infected
A. mellifera larvae, leading to the discovery that the
infected state is associated with an elevated expression of
immunity proteins, chaperones, certain metabolic pro-
teins with an accelerated consumption of energy stores.
One particular immune factor, proPO, was particularly
up-regulated in response to infection. Intriguingly, the
activity level of this enzyme during development of larvae
Mass spectrometry-based peptide analysis for prophenoloxi- dase (proPO) Figure 3
Mass spectrometry-based peptide analysis for proph-
enoloxidase (proPO). Protein domains [22] of proPO are 
shown in row I. Notable regions [19] and protein length are 
shown in row II. Row III describes the average quantity of 
three peptides in infected larval hemolymph, represented by 
a color scale to depict fold-differences relative to healthy 
controls (black). Peptides used in averages and their statisti-
cal significances using the two-tailed, paired t-teset: n = 3 for 
SVATQVFNR (p < 0.05), n = 3 for GLDFTPR (p < 0.1), n = 5 
for SSVTIPFER (p < 0.05). Averages were generated by con-
sidering values from both infection methods (PL-Scale and 
PL-Lab) together.
.....................................................................................................
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appears to correlate very tightly with susceptibility of the
larvae to infection. Our data support a model where the
host larva responds to infection not only by producing
proteins that can fight the infection directly, but also by
engaging its metabolic pathways and energy resources
required to support the effort.
The observed depletion of energy stores in the form of
MRJPs, hexamerins and lipid transporters suggest that the
observed up-regulation of metabolic enzymes is, at least
in part, tied to energy production. In larvae infected with
E. coli, which is not a natural pathogen of bees, MRJP-1,
MRJP-7/MRJP-2 were mildly lowered in expression com-
pared to the mock-infected control [12]. The negative cor-
relation between energy availability and infection survival
has also been observed in other insects such as the butter-
fly Pieris rapa [24] and the bumblebee Bombus terrestris
[25]. In further support of the increased energy demands
of the infected state, the putative bee neuropeptide Y
receptor was also up-regulated in infected larvae. While
the ligand for this receptor in bees remains unknown, the
receptor and its cognate ligand in mammals control feed-
ing and appetite in mammals [26].
The most obvious class of proteins expected to increase in
response to infection are those involved in the innate
immune response. Lysozyme's primary known function is
to degrade the peptidoglycan shell of Gram-positive bac-
teria [27] and is therefore expected to have a significant
role in inhibiting P. larvae. Interestingly, the C-type lys-
ozyme [GI:110762174] that has been previously shown
to be up-regulated upon infection [10] is not the lysozyme
we have identified here, which is also known as the desta-
bilase-lysozyme [GI: 6656246]. Because these two forms
are drastically different (e.g., the best-matched region is
only 50 amino acids long and shares only 20% sequence
identity), it is clearly not a case of the peptides identified
by MS/MS being shared by both enzymes. The 13- to 16-
fold up-regulation of destabilase-lysozyme suggests that it
can be important in host defense, which is also supported
by the observation that its homolog has antimicrobial
activity in the medicinal leech Hirudo medicinalis [28]. The
AMPs comprise another humoral-based defense mecha-
nism, killing Gram-negative and positive bacteria alike
[12,29]; many of them work by forming pores in the bac-
terial cell wall. Among those known in bees, we were only
able to quantify hymenoptaecin in the hemolymph, and
its dramatic up-regulation suggests that it plays a crucial
role in defending against P. larvae, a conclusion that is
supported by other reports [10,12]. Conspicuously absent
in our data, however, are defensin and abaecin, which
have both been implicated in the larval response to P. lar-
vae [6-10]. Although we detected peptides from defensin,
Hemolymph fractionation Figure 4
Hemolymph fractionation. (a) Hemolymph from fourth- 
and fifth-instar larvae was fractionated by strong anion 
exchange using a step gradient of increasing salt. Each frac-
tion (A-F from 0.04 M to 0.24 M salt in 0.04 M increments, 
plus DS = desalted hemolymph, and FT = flowthrough) was 
normalized by protein concentration and was subjected to a 
PO assay (see Methods). Activity is represented by relative 
reaction rates to DS (left axis, bars). Using mass spectrome-
try, proPO levels were measured relative to the fraction 
containing the highest activity (Fraction D), shown on a natu-
ral log scale (N = 3). This was accomplished by averaging the 
ratio of at least two peptides for proPO in a differentially 
label mixture of peptides from Fraction F versus the remain-
ing fractions. Error bars = 2 standard deviations. As an exam-
ple in (b), two spectra of the differentially labeled (+28Da 
and +32Da) peptide FSDTIVPR is shown at a 1:1 mixture of 
peptides from (I) Fraction D and sample DS and (II) Fraction 
D and E.
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the signal:noise ratios in the MS1 spectra were not high
enough to allow accurate quantitation; no abaecin pep-
tides were detected. Our inability to detect these two
AMPs with sufficient signal suggests that their concentra-
tion is likely much lower than hymenoptaecin, which is
confirmed by a recent one-dimensional (1D) gel electro-
phoresis study of larval hemolymph [12].
The consistent up-regulation of proPO in both infection
methods is in agreement with the well-characterized anti-
microbial activity of this enzyme. The ability of larvae to
employ melanization as a defense mechanism has been
questioned because the proPO levels are low compared to
adults, to the point of being undetectable on a stained 1D
gel [12]. In our own experiments, even with ion-exchange
fractionation prior to LC-MS/MS analysis on an LTQ-
OrbitrapXL, one of the most sensitive systems available, it
was difficult to detect throughout most of larval develop-
ment except for the oldest samples (5 d post-hatching)
[11]. However, we are clearly able to detect PO activity as
early as three days after hatching, where the absence of
activity in the earlier timepoints (days 1 and 2) precisely
match the period of maximum susceptibility of the larvae
to AFB [1,30]. Thus, our data argue that older larvae have
significant levels of PO and that they are indeed capable
of utilizing the PO pathway to fight infection.
Conclusion
The larval stage of a honey bee represents a unique system
for applying proteomics to probe host-pathogen interac-
tions. Unlike most other systems, proteins in larvae not
only play major roles in immune defense but also consti-
tute one of their primary stores of energy. Studying such a
response in most other systems with more conventional
energy reserves (e.g., lipids) would necessitate a wide vari-
ety of tools in order to monitor energy usage, immune fac-
tor production and metabolic flux all at the same time. By
monitoring all these aspects simultaneously, our data
clearly demonstrate that host defense against bacterial
challenge is a concerted response involving proteins that
kill the microbes directly, as well as metabolic and cell/
protein repair enzymes that indirectly support this defen-
sive effort. By using proteomics techniques on this unique
model organism where immunity and protein energy flux
are tightly coupled, we have been able to build a more
comprehensive picture of the insect innate immune
response.
Methods
Honey bees and infection experiments
All infection experiments were conducted at Beaverlodge,
AB, Canada during July and August of 2005. Three five-
frame nucleus colonies ('nucs') were prepared with three
frames of bees and open brood and with newly-mated sis-
ter queens. In each nuc, 100 by 100 mm patches of first
instar larvae were selected and sprayed with 20 mL of one
of the following: 1) a 6.0E+06 spores/mL suspension of
spores isolated from naturally occurring AFB 'scale' col-
lected in 2004 (PL-Scale), 2) a 4.4E+06 spores/mL suspen-
sion of spores from NRRL B-3650 (PL-Lab), a virulent
laboratory strain of P. larvae (courtesy of Jay Evans), and
3) phosphate-buffered saline (PBS).
Sample collection and processing for MS
Four days after infection larvae (estimated to be in late
fourth or fifth instar) within each marked square (PL-
Scale, PL-Lab and control) were extracted using soft for-
ceps (Bioquip, Rancho Dominguez, CA) and bled as
described [11]. Hemolymph was processed as described
for larvae in [31]. In each case, we compared 20 μg of pro-
tein from infected hemolymph with the control by differ-
ential labeling of tryptic peptides using light (C1H2O) and
heavy (C2H2O) isotopologs of formaldehyde prior to
analysis by liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) using a linear trapping quadrupole-
OrbitrapXL exactly as described [11].
MS data analysis
Raw data processing to arrive at peptide ion volume ratios
was performed exactly as described [11]. Data for each
infection method were pooled, and proteins with five or
more quantified peptides from any one or all of the repli-
cates were considered quantified. This approach operates
on the underlying assumption that each peptide ratio is a
technical replicate, which is different from most publica-
Phenoloxidase activity assays Figure 5
Phenoloxidase activity assays. Protein concentration-
normalized hemolymph was collected over the first five days 
of larval development. The PO activity assay (see Methods) 
was conducted on the samples, where activity is represented 
here by the maximum A520 attained by the samples. All PO 
assay measurements were performed in triplicate. Error bars 
= 2 standard deviations.
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tions where averages are made at the protein, not the pep-
tide level. The conventional method implies that a protein
quantified from averaging over a large number of quanti-
fied peptides has the same statistical power than one
quantified with the bare minimum. To circumvent this
disadvantage, we took single peptides from three biologi-
cal replicates as individual data points, which reasonably
accounts for the greater statistical power afforded by well-
detected proteins with many quantified peptides. The
average level of protein regulation is represented by the
median peptide ratio. We employed the two-tailed Wil-
coxon matched-pairs signed-ranked test on these proteins
using Analyse-It (v2.12, http://www.analyse-it.com/),
with peptides as data points to assess whether the expres-
sion level of each protein was significantly changed by
infection at 95% and 99% confidence [32]. For proteins
with more than 100 peptides, the 100 most intense
[M+nH]n+ ions (heavy and light combined, n ≥ 2) were
selected for analysis. The same test was used on peptides
quantified in both infection methods to assess whether
the two methods yielded the same effects on protein
expression. Experimentally or bioinformatically-inferred
evidence of protein functions and names discussed
throughout this report is provided in Additional File 4.
Hemolymph collection for PO activity assay
We collected honey bee larvae and estimated their age in
days by size. Animals at each age were pooled to collect at
least 8 μL of hemolymph per replicate for three replicates
– the number of larvae required varied from approxi-
mately 150 for the very young larvae, and 2–5 for the old-
est larvae tested (five days old); 18 fourth to fifth instar
larvae were pooled and used for the fractionation experi-
ment and processed as described for larvae in [31]. Pro-
tein concentrations were assayed by Coomassie Plus
(except in the protein fractionation experiment, see
below) and were normalized across all samples using
Assay Buffer (20 mM Tris-HCl, pH 8).
Hemolymph fractionation
Hemolymph was desalted using a mini Zeba column
(Pierce) according to the manufacturer's instructions. Of
the 75 μL total volume, 25 μL was reserved for MS analy-
sis. The remainder was applied to a mini strong anion
exchange column (Pierce), and washed with 100 μL of
Assay Buffer between step-elutions of a 10-step sodium
chloride gradient prepared in Assay Buffer: 0.04, 0.08,
0.12, 0.16, 0.20, 0.24, 0.28, 0.32, 0.36, 0.40, 0.50, 1.0, 2.0
M. Protein concentrations of all the fractions, including
the flow-through and desalted hemolymph, were esti-
mated by absorbance at 280 nm. Fractions eluted from
0.28 M or higher salt had negligible amounts of protein
and were not further analyzed. The protein concentration
of the other fractions was equalized using Assay Buffer.
For each fraction we then measured the PO activity using
an enzyme assay (see below) and levels of each protein
relative to the 0.16 M NaCl fraction. At least 2 peptides of
PO were used for calculating the average PO level in each
fraction. In cases where peptide ratios were above 50-fold
and likely beyond the linear dynamic range of the ratio
measurements, the high ratios were arbitrarily given the
same value as the next highest ratio value below 50-fold.
In solution phenoloxidase assay
Conducted as described [20], substrate (8 μL of 5 mM 4-
methylcatechol (Sigma) and 8 μL of 40 mM 4-hydroxy-
proline ethyl ester) was added to 8 μL of hemolymph to
start the reaction, except for the experiment with larvae of
different ages where the hemolymph:subtrate ratio was
4:1. Absorbance readings at 520 nm were taken immedi-
ately using a Nanodrop spectrophotometer (ND-1000,
ThermoFisher Scientific) to calculate the initial reaction
rate (ΔA520/ΔT). For larval aging experiments, instead of
the rate, the maximum A520 value was recorded after the
highest level was reached in approximately 40 min.
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